312 related articles for article (PubMed ID: 15818381)
1. Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.
Greco O; Powell TM; Marples B; Joiner MC; Scott SD
Cancer Gene Ther; 2005 Jul; 12(7):655-62. PubMed ID: 15818381
[TBL] [Abstract][Full Text] [Related]
2. Development of synthetic promoters for radiation-mediated gene therapy.
Marples B; Scott SD; Hendry JH; Embleton MJ; Lashford LS; Margison GP
Gene Ther; 2000 Mar; 7(6):511-7. PubMed ID: 10757025
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
4. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
5. Optimization of radiation controlled gene expression by adenoviral vectors in vitro.
Anton M; Gomaa IE; von Lukowicz T; Molls M; Gansbacher B; Würschmidt F
Cancer Gene Ther; 2005 Jul; 12(7):640-6. PubMed ID: 15803145
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on lung carcinoma-targeted suicide gene therapy induced by irradiation].
Wang WD; Chen ZT; Li DZ; Duan YZ; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):84-7. PubMed ID: 12783658
[TBL] [Abstract][Full Text] [Related]
7. Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.
Scott SD; Joiner MC; Marples B
Gene Ther; 2002 Oct; 9(20):1396-402. PubMed ID: 12365005
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
Namba H; Tagawa M; Miyagawa T; Iwadate Y; Sakiyama S
Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
[TBL] [Abstract][Full Text] [Related]
9. Combine cancer gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and Herpes simplex thymidine kinase suicide gene.
Pastorakova A; Hlubinova K; Jakubikova J; Altaner C
Neoplasma; 2006; 53(5):353-62. PubMed ID: 17013529
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated tissue-targeted expression of the HSVtk gene for the treatment of breast cancer.
Anderson LM; Swaminathan S; Zackon I; Tajuddin AK; Thimmapaya B; Weitzman SA
Gene Ther; 1999 May; 6(5):854-64. PubMed ID: 10505111
[TBL] [Abstract][Full Text] [Related]
11. Suicide gene therapy using AAV-HSVtk/ganciclovir in combination with irradiation results in regression of human head and neck cancer xenografts in nude mice.
Kanazawa T; Mizukami H; Okada T; Hanazono Y; Kume A; Nishino H; Takeuchi K; Kitamura K; Ichimura K; Ozawa K
Gene Ther; 2003 Jan; 10(1):51-8. PubMed ID: 12525837
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system.
Parada C; Hernández Losa J; Guinea J; Sánchez-Arévalo V; Fernández Soria V; Alvarez-Vallina L; Sánchez-Prieto R; Ramón y Cajal S
Cancer Gene Ther; 2003 Feb; 10(2):152-60. PubMed ID: 12536204
[TBL] [Abstract][Full Text] [Related]
14. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
[TBL] [Abstract][Full Text] [Related]
15. [Gene therapy of a model of glioblastoma in rats using adenovirus vector encoding the HSVtk gene].
Quillien V; Heresbach Le Berre N; Dufour T; Denais A; Guegan Y; Ferry N; Bloin V
Bull Cancer; 1997 Nov; 84(11):1047-52. PubMed ID: 9536986
[TBL] [Abstract][Full Text] [Related]
16. Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme.
Rainov NG; Kramm CM; Banning U; Riemann D; Holzhausen HJ; Heidecke V; Burger KJ; Burkert W; Körholz D
Gene Ther; 2000 Nov; 7(21):1853-8. PubMed ID: 11110418
[TBL] [Abstract][Full Text] [Related]
17. Suicide gene therapy of human breast cancer in SCID mice model by the regulation of Tet-On.
Hu WX; Zeng ZJ; Luo SQ; Chen Q
Chin Med J (Engl); 2004 Mar; 117(3):434-9. PubMed ID: 15043787
[TBL] [Abstract][Full Text] [Related]
18. Targeted gene therapy of ovarian cancer using an ovarian-specific promoter.
Bao R; Selvakumaran M; Hamilton TC
Gynecol Oncol; 2002 Feb; 84(2):228-34. PubMed ID: 11812079
[TBL] [Abstract][Full Text] [Related]
19. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
Zerrouqi A; Rixe O; Ghoumari AM; Yarovoi SV; Mouawad R; Khayat D; Soubrane C
Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
[TBL] [Abstract][Full Text] [Related]
20. [Oncostatin M gene therapy in mice bearing lung adenocarcinoma xenograft using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):240-3. PubMed ID: 15144614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
